Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 2
2011 1
2012 2
2013 2
2014 1
2015 1
2016 3
2017 1
2018 3
2019 3
2020 7
2021 7
2022 2
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Correlation between Histopathological Prognostic Tumor Characteristics and [18F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic Breast Cancer.
Boers J, Eisses B, Zwager MC, van Geel JJL, Bensch F, de Vries EFJ, Hospers GAP, Glaudemans AWJM, Brouwers AH, den Dekker MAM, Elias SG, Kuip EJM, van Herpen CML, Jager A, van der Veldt AAM, Oprea-Lager DE, de Vries EGE, van der Vegt B, Menke-van der Houven van Oordt WC, Schröder CP; IMPACT-Metastatic Breast Consortium. Boers J, et al. Among authors: schroder cp. Diagnostics (Basel). 2024 Feb 14;14(4):416. doi: 10.3390/diagnostics14040416. Diagnostics (Basel). 2024. PMID: 38396455 Free PMC article.
Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial.
Wildiers H, Armstrong A, Cuypere E, Dalenc F, Dirix L, Chan S, Marme F, Schröder CP, Huober J, Duhoux FP, Vuylsteke P, Jager A, Brain E, Kuemmel S, Pápai Z, Menke-van der Houven van Oordt CW, Perjesi L, Mueller C, Brignone C, Triebel F. Wildiers H, et al. Among authors: schroder cp. Clin Cancer Res. 2024 Feb 1;30(3):532-541. doi: 10.1158/1078-0432.CCR-23-1173. Clin Cancer Res. 2024. PMID: 37939105 Free PMC article. Clinical Trial.
Molecular imaging as biomarker for treatment response and outcome in breast cancer.
van Geel JJL, de Vries EFJ, van Kruchten M, Hospers GAP, Glaudemans AWJM, Schröder CP. van Geel JJL, et al. Among authors: schroder cp. Ther Adv Med Oncol. 2023 May 18;15:17588359231170738. doi: 10.1177/17588359231170738. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37223262 Free PMC article. Review.
Clinical Validity of 16α-[18F]Fluoro-17β-Estradiol Positron Emission Tomography/Computed Tomography to Assess Estrogen Receptor Status in Newly Diagnosed Metastatic Breast Cancer.
van Geel JJL, Boers J, Elias SG, Glaudemans AWJM, de Vries EFJ, Hospers GAP, van Kruchten M, Kuip EJM, Jager A, Menke-van der Houven van Oordt WC, van der Vegt B, de Vries EGE, Schröder CP; IMPACT-Metastatic Breast Consortium. van Geel JJL, et al. Among authors: schroder cp. J Clin Oncol. 2022 Nov 1;40(31):3642-3652. doi: 10.1200/JCO.22.00400. Epub 2022 May 18. J Clin Oncol. 2022. PMID: 35584346
First-time imaging of [89Zr]trastuzumab in breast cancer using a long axial field-of-view PET/CT scanner.
Brouwers AH, van Sluis J, van Snick JH, Schröder CP, Baas IO, Boellaard R, Glaudemans AWJM, Borra RJH, Lammertsma AA, Dierckx RAJO, Tsoumpas C. Brouwers AH, et al. Among authors: schroder cp. Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3593-3595. doi: 10.1007/s00259-022-05777-x. Epub 2022 Apr 1. Eur J Nucl Med Mol Imaging. 2022. PMID: 35362794 Free PMC article. No abstract available.
35 results